Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Presence of osteoclast precursor cells during ex vivo expansion of bone marrow-derived mesenchymal stem cells for autologous use in cell therapy.

Allers C, Lasala GP, Minguell JJ.

Cytotherapy. 2014 Apr;16(4):454-9. doi: 10.1016/j.jcyt.2013.08.006. Epub 2013 Oct 29.

PMID:
24176545
[PubMed - in process]
2.

Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.

Mauney JR, Volloch V, Kaplan DL.

Biomaterials. 2005 Nov;26(31):6167-75.

PMID:
15913765
[PubMed - indexed for MEDLINE]
3.

[Age-related biological characteristics of human bone marrow mesenchymal stem cells from different age donors].

Huang K, Zhou DH, Huang SL, Liang SH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Dec;13(6):1049-53. Chinese.

PMID:
16403278
[PubMed - indexed for MEDLINE]
4.

Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow.

Mareschi K, Ferrero I, Rustichelli D, Aschero S, Gammaitoni L, Aglietta M, Madon E, Fagioli F.

J Cell Biochem. 2006 Mar 1;97(4):744-54.

PMID:
16229018
[PubMed - indexed for MEDLINE]
5.

Ex vivo expansion and in vivo infusion of bone marrow-derived Flk-1+CD31-CD34- mesenchymal stem cells: feasibility and safety from monkey to human.

Liu L, Sun Z, Chen B, Han Q, Liao L, Jia M, Cao Y, Ma J, Sun Q, Guo M, Liu Z, Ai H, Zhao RC.

Stem Cells Dev. 2006 Jun;15(3):349-57.

PMID:
16846373
[PubMed - indexed for MEDLINE]
6.

Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.

Mauney JR, Kirker-Head C, Abrahamson L, Gronowicz G, Volloch V, Kaplan DL.

J Biomed Mater Res A. 2006 Dec 1;79(3):464-75.

PMID:
16752403
[PubMed - indexed for MEDLINE]
7.

Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy.

Koç ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, Lazarus HM.

J Clin Oncol. 2000 Jan;18(2):307-16.

PMID:
10637244
[PubMed - indexed for MEDLINE]
Free Article
8.

[Biological characteristics of mesenchymal stem cells in human umbilical cord blood and their supporting capacities in ex vivo expansion of CD34+ hematopoietic stem cells].

Wang LJ, Zhang YP, Wang JF, Wu YF, Xiang Y, Xie CG, Jia BB, Harrington J, McNiece IK.

Zhonghua Xue Ye Xue Za Zhi. 2005 Feb;26(2):65-8. Chinese.

PMID:
15921619
[PubMed - indexed for MEDLINE]
9.

Improved isolation and expansion of bone marrow mesenchymal stromal cells using a novel marrow filter device.

Otsuru S, Hofmann TJ, Olson TS, Dominici M, Horwitz EM.

Cytotherapy. 2013 Feb;15(2):146-53. doi: 10.1016/j.jcyt.2012.10.012. Epub 2012 Dec 6.

PMID:
23321326
[PubMed - indexed for MEDLINE]
10.

Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome.

Chapel A, Bertho JM, Bensidhoum M, Fouillard L, Young RG, Frick J, Demarquay C, Cuvelier F, Mathieu E, Trompier F, Dudoignon N, Germain C, Mazurier C, Aigueperse J, Borneman J, Gorin NC, Gourmelon P, Thierry D.

J Gene Med. 2003 Dec;5(12):1028-38.

PMID:
14661178
[PubMed - indexed for MEDLINE]
11.

Use of autologous human mesenchymal stromal cell/fibrin clot constructs in upper limb non-unions: long-term assessment.

Giannotti S, Trombi L, Bottai V, Ghilardi M, D'Alessandro D, Danti S, Dell'Osso G, Guido G, Petrini M.

PLoS One. 2013 Aug 30;8(8):e73893. doi: 10.1371/journal.pone.0073893. eCollection 2013. Erratum in: PLoS One. 2013;8(11). doi:10.1371/annotation/e4403abb-b80e-43c5-be74-1bdb2c899d1c.

PMID:
24023694
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Ex vivo expansion of mesenchymal stromal cells.

Bernardo ME, Cometa AM, Pagliara D, Vinti L, Rossi F, Cristantielli R, Palumbo G, Locatelli F.

Best Pract Res Clin Haematol. 2011 Mar;24(1):73-81. doi: 10.1016/j.beha.2010.11.002. Epub 2011 Feb 23. Review.

PMID:
21396595
[PubMed - indexed for MEDLINE]
13.

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

Duijvestein M, Vos AC, Roelofs H, Wildenberg ME, Wendrich BB, Verspaget HW, Kooy-Winkelaar EM, Koning F, Zwaginga JJ, Fidder HH, Verhaar AP, Fibbe WE, van den Brink GR, Hommes DW.

Gut. 2010 Dec;59(12):1662-9. doi: 10.1136/gut.2010.215152. Epub 2010 Oct 4.

PMID:
20921206
[PubMed - indexed for MEDLINE]
14.

Human mesenchymal stem cell proliferation and osteogenic differentiation during long-term ex vivo cultivation is not age dependent.

Fickert S, Schröter-Bobsin U, Gross AF, Hempel U, Wojciechowski C, Rentsch C, Corbeil D, Günther KP.

J Bone Miner Metab. 2011 Mar;29(2):224-35. doi: 10.1007/s00774-010-0215-y. Epub 2010 Sep 2.

PMID:
20811759
[PubMed - indexed for MEDLINE]
15.

Characterization of placenta-derived mesenchymal stem cells cultured in autologous human cord blood serum.

Wang L, Yang Y, Zhu Y, Ma X, Liu T, Zhang G, Fan H, Ma L, Jin Y, Yan X, Wei J, Li Y.

Mol Med Rep. 2012 Oct;6(4):760-6. doi: 10.3892/mmr.2012.1000. Epub 2012 Jul 23.

PMID:
22824952
[PubMed - indexed for MEDLINE]
16.

Reconstitution of marrow-derived extracellular matrix ex vivo: a robust culture system for expanding large-scale highly functional human mesenchymal stem cells.

Lai Y, Sun Y, Skinner CM, Son EL, Lu Z, Tuan RS, Jilka RL, Ling J, Chen XD.

Stem Cells Dev. 2010 Jul;19(7):1095-107. doi: 10.1089/scd.2009.0217.

PMID:
19737070
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis.

Choi MR, Kim HY, Park JY, Lee TY, Baik CS, Chai YG, Jung KH, Park KS, Roh W, Kim KS, Kim SH.

Neurosci Lett. 2010 Mar 19;472(2):94-8. doi: 10.1016/j.neulet.2010.01.054. Epub 2010 Feb 1.

PMID:
20117176
[PubMed - indexed for MEDLINE]
18.

Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.

Pérez-Ilzarbe M, Díez-Campelo M, Aranda P, Tabera S, Lopez T, del Cañizo C, Merino J, Moreno C, Andreu EJ, Prósper F, Pérez-Simón JA.

Transfusion. 2009 Sep;49(9):1901-10. doi: 10.1111/j.1537-2995.2009.02226.x. Epub 2009 May 20.

PMID:
19497059
[PubMed - indexed for MEDLINE]
19.

Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood.

Huang GP, Pan ZJ, Jia BB, Zheng Q, Xie CG, Gu JH, McNiece IK, Wang JF.

Cell Transplant. 2007;16(6):579-85.

PMID:
17912949
[PubMed - indexed for MEDLINE]
20.

Effects of high-dose chemotherapy on bone marrow multipotent mesenchymal stromal cells isolated from lymphoma patients.

Prata Kde L, Orellana MD, De Santis GC, Kashima S, Fontes AM, Carrara Rde C, Palma PV, Neder L, Covas DT.

Exp Hematol. 2010 Apr;38(4):292-300.e4. doi: 10.1016/j.exphem.2010.01.006. Epub 2010 Feb 6.

PMID:
20138957
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk